---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "H0iuzt/mtQUO4OSS03Ejd/F8p6IC8RzqHUNMMAEmkY9xVFfcIhU69MV2d8gpeYS/aeOqjXZ6WIRrnxS53L7d98A7QbT6UsnAKOyaDY7pi5op78KtOL05k/FvZzItztF8G4/e3oKC17UINqWwZqhQwbYiP9qHF1BxwWNSDgw3RMANmyD/NeHEzWftf+3a2KGlYntk/h+RmB+xpHyGC59UxKseDjRFj7p1AG62CfoSMAwoobCQyYB8rzA7L+Xu0IoTDBwCBSdmaJQUXk/h46mAT87WNS6TyKmdwk5OadXwlS+HjnvteShtQIcAeAhkhJ+v;utb0Fe5t5tQTs0la6CpRkQ=="
---

